Want to see HSIC full AI Analyst Report?
HSIC Stock Chart & Stats
$78.83
-$1.28(-1.78%)
At close: 4:00 PM EST
$78.83
-$1.28(-1.78%)
Day’s Range― - ―
52-Week Range$61.95 - $89.29
Previous CloseN/A
Volume226.89K
Average Volume (3M)1.28M
Market Cap
$9.85B
Enterprise Value$12.72B
Total Cash (Recent Filing)$138.00M
Total Debt (Recent Filing)$3.75B
Price to Earnings (P/E)25.9
Beta0.29
Next Earnings
Aug 11, 2026EPS Estimate
1.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.34
Shares Outstanding113,916,756
10 Day Avg. Volume1,389,561
30 Day Avg. Volume1,278,409
Financial Highlights & Ratios
PEG Ratio3.23
Price to Book (P/B)2.83
Price to Sales (P/S)0.70
P/FCF Ratio16.05
Enterprise Value/Market Cap1.29
Enterprise Value/Revenue0.95
Enterprise Value/Gross Profit3.20
Enterprise Value/Ebitda12.70
Forecast
1Y Price Target
$87.50Price Target Upside11.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)5.35
Revenue Forecast (FY)$13.75B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables & Distribution ScaleHenry Schein's core business is high-frequency consumables and distribution to dental and medical practices, producing predictable, recurring revenue. Scale and supplier relationships enable broad product availability and frequent reorder behavior, supporting long-term top-line stability and customer stickiness across cycles.
Technology & Services MomentumRapid cloud and software adoption (roughly 25% subscriber growth) and accelerating e-commerce shift move revenue mix toward higher-margin, recurring service fees. Over time this increases predictable revenue, enhances gross-profit durability, and raises switching costs as practices integrate software and platform services.
Clear Cost-Improvement & Value Creation TargetsManagement’s explicit targets (> $200M long-term, $125M run-rate by end-2026) provide a multi-year framework to restore operating leverage. Concrete initiatives (procurement, outsourced back-office, pricing actions) can structurally expand margins and free cash flow if execution remains on track, reducing cyclical exposure.
Bears Say
Rising LeverageDebt has materially increased versus prior years, pushing leverage to roughly 1.15x equity. Higher indebtedness reduces financial flexibility, raises interest‑cost sensitivity to rate moves, and limits the company's capacity to fund buybacks, M&A, or absorb macro shocks without pressuring credit metrics or requiring slower deleveraging.
Compressed Net MarginsDespite stable gross margins, net margin has fallen materially from earlier peaks, reflecting structural profitability pressure. Mix shifts, pricing competition in digital equipment and implants, and elevated operating costs reduce the earnings cushion, making bottom-line performance more sensitive to cost inflation and execution slippage.
Weaker & Volatile Cash GenerationFree cash flow has downshifted recently and operating cash flow remains a modest share of revenue, with seasonal swings (negative Q1 OCF noted). Weaker, more volatile cash conversion constrains capacity to pay down debt, sustain buybacks, or invest in tech without relying on external financing during weaker periods.
Henry Schein News
HSIC FAQ
What was Henry Schein’s price range in the past 12 months?
Henry Schein lowest stock price was $61.95 and its highest was $89.29 in the past 12 months.
What is Henry Schein’s market cap?
Henry Schein’s market cap is $9.85B.
When is Henry Schein’s upcoming earnings report date?
Henry Schein’s upcoming earnings report date is Aug 11, 2026 which is in 38 days.
How were Henry Schein’s earnings last quarter?
Henry Schein released its earnings results on May 05, 2026. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.218 by $0.102.
Is Henry Schein overvalued?
According to Wall Street analysts Henry Schein’s price is currently Undervalued.
Does Henry Schein pay dividends?
Henry Schein does not currently pay dividends.
What is Henry Schein’s EPS estimate?
Henry Schein’s EPS estimate is 1.24.
How many shares outstanding does Henry Schein have?
Henry Schein has 113,916,756 shares outstanding.
What happened to Henry Schein’s price movement after its last earnings report?
Henry Schein reported an EPS of $1.32 in its last earnings report, beating expectations of $1.218. Following the earnings report the stock price went up 3.263%.
Which hedge fund is a major shareholder of Henry Schein?
Currently, no hedge funds are holding shares in HSIC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Henry Schein Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$87.50 (11.00% Upside)
$87.50 (11.00% Upside)
Blogger Sentiment
Bullish
HSIC Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 170.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $691.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.19%
12-Months-Change
Fundamentals
Return on Equity
11.86%
Trailing 12-Months
Asset Growth
7.86%
Trailing 12-Months
Company Description
Henry Schein
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
HSIC Company Deck
HSIC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple strong operational and financial positives — solid revenue growth (+6.3% total, 2.5% internal), non-GAAP margin expansion (+28 bps), adjusted EBITDA growth (+11.6%), cloud/customer momentum (+25% cloud subscribers), rapid e-commerce adoption (80%+ U.S. dental e-commerce), and an explicit multi-year value-creation plan with a $125 million 2026 run-rate target and a >$200 million longer-term target. Offsetting these were manageable but important risks: a Q1 GAAP margin dip and slight GAAP net income decline, negative Q1 operating cash flow (seasonal), softness in medical diagnostics due to a light flu season, digital equipment ASP pressure, restructuring costs ($12M in Q1), and exposure to rising oil/freight costs. Overall, the positives (growth, margin expansion on a non-GAAP basis, technology and e-commerce traction, and clear cost-transformation initiatives) materially outweigh the near-term headwinds and execution costs, supporting an optimistic outlook grounded with prudent caveats around macro and timing of savings.View all HSIC earnings summariesHSIC Revenue Breakdown
84.48% Global Distribution and Value-Added Services
11.71% Global Specialty Products
5.12% Global Technology
-1.31% Eliminations

HSIC Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$87.50
▲(11.00% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
1.33% Insiders
29.08% Mutual Funds
43.46% Other Institutional Investors
2.62% Public Companies and
Individual Investors







